Immune Checkpoint Inhibitors in Peripheral T-Cell Lymphoma

Peripheral T-cell lymphomas (PTCLs) are highly heterogeneous and present significant treatment challenges. Immune checkpoint therapies, such as PD-1 and CTLA-4 inhibitors, have significantly changed the clinical management paradigm of tumors. The roles of immune checkpoints in PTCL and related agent...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xi, Wu, Wanchun, Wei, Wenwen, Zou, Liqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086454/
https://www.ncbi.nlm.nih.gov/pubmed/35559250
http://dx.doi.org/10.3389/fphar.2022.869488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086454/
https://www.ncbi.nlm.nih.gov/pubmed/35559250
http://dx.doi.org/10.3389/fphar.2022.869488

Ejemplares similares